Canada - inglese - Health Canada

dominion pharmacal - moclobemide - tablet - 150mg - moclobemide 150mg - monoamine oxidase inhibitors

Canada - inglese - Health Canada

dominion pharmacal - moclobemide - tablet - 300mg - moclobemide 300mg - monoamine oxidase inhibitors

Canada - inglese - Health Canada

apotex inc - hydroxyurea - capsule - 500mg - hydroxyurea 500mg - antineoplastic agents

Stati Uniti - inglese - NLM (National Library of Medicine)

physicians total care, inc. - hydroxyurea (unii: x6q56qn5qc) (hydroxyurea - unii:x6q56qn5qc) - hydroxyurea 500 mg - significant tumor response to hydroxyurea capsules usp has been demonstrated in melanoma, resistant chronic myelocytic leukemia, and recurrent, metastatic, or inoperable carcinoma of the ovary. hydroxyurea, usp used concomitantly with irradiation therapy is intended for use in the local control of primary squamous cell (epidermoid) carcinomas of the head and neck, excluding the lip. hydroxyurea is contraindicated in patients with marked bone marrow depression, i.e., leukopenia (< 2500 wbc) or thrombocytopenia (< 100,000), or severe anemia. hydroxyurea capsules are contraindicated in patients who have demonstrated a previous hypersensitivity to hydroxyurea or any other component of its formulation.

Stati Uniti - inglese - NLM (National Library of Medicine)

henry schein animal health - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide 0.5 mg

Stati Uniti - inglese - NLM (National Library of Medicine)

vedco, inc. - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide 0.5 mg

Stati Uniti - inglese - NLM (National Library of Medicine)

boehringer ingelheim vetmedica, inc. - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide 0.5 mg

Stati Uniti - inglese - NLM (National Library of Medicine)

alaven pharmaceutical llc - oxymetholone (unii: l76t0zca8k) (oxymetholone - unii:l76t0zca8k) - oxymetholone 50 mg - anadrol® -50 tablets is indicated in the treatment of anemias caused by deficient red cell production. acquired aplastic anemia, congenital aplastic anemia, myelofibrosis and the hypoplastic anemias due to the administration of myelotoxic drugs often respond. anadrol® -50 tablets should not replace other supportive measures such as transfusion, correction of iron, folic acid, vitamin b12 or pyridoxine deficiency, antibacterial therapy and the appropriate use of corticosteroids. controlled substance: anadrol®-50 tablets is considered to be a controlled substance and is listed in schedule iii.

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - clomifene citrate - oral tablet - 50mg

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi - clomifene citrate - oral tablet - 50mg